In pediatric AD, elevated Th2/Th22 cytokines (IL-13, IL-22), reduced NMF, increased transepidermal water loss, and FLG mutations are associated with more severe disease and a higher risk of comorbid conditions such as asthma and food allergies. This evidence concerns the gene IL22 and Alzheimer disease.